Israel Englander’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.2M Sell
94,149
-291,997
-76% -$13.8M ﹤0.01% 3156
2026
Q1
$19.9M Buy
386,146
+184,006
+91% +$12.9M 0.01% 1555
2025
Q4
$18.6M Sell
202,140
-154,668
-43% -$14.8M 0.01% 1644
2025
Q3
$26.5M Buy
+356,808
New +$36.1M 0.01% 1365
2025
Q2
Sell
-16,246
Closed -$2.36M 6091
2025
Q1
$2.59M Buy
16,246
+11,195
+222% +$2.03M ﹤0.01% 3537
2024
Q4
$936K Sell
5,051
-2,475
-33% -$480K ﹤0.01% 4257
2024
Q3
$1.59M Sell
7,526
-24,800
-77% -$4.31M ﹤0.01% 3913
2024
Q2
$4.33M Buy
32,326
+18,236
+129% +$3.45M ﹤0.01% 2858
2024
Q1
$3.03M Buy
14,090
+1,131
+9% +$222K ﹤0.01% 3353
2023
Q4
$2.64M Sell
12,959
-306,744
-96% -$49.7M ﹤0.01% 3379
2023
Q3
$63.4M Buy
319,703
+55,263
+21% +$13.9M 0.03% 561
2023
Q2
$85.8M Buy
264,440
+112,357
+74% +$32.1M 0.04% 435
2023
Q1
$35.6M Sell
152,083
-63,063
-29% -$15.9M 0.02% 911
2022
Q4
$54.2M Buy
215,146
+205,813
+2,205% +$43.9M 0.03% 706
2022
Q3
$1.66M Buy
9,333
+1,114
+14% +$224K ﹤0.01% 3919
2022
Q2
$1.5M Sell
8,219
-77,467
-90% -$15.4M ﹤0.01% 3990
2022
Q1
$22M Buy
85,686
+2,465
+3% +$563K 0.01% 1297
2021
Q4
$19.1M Buy
83,221
+64,276
+339% +$15.7M 0.01% 1478
2021
Q3
$4.41M Sell
18,945
-140,599
-88% -$29.3M ﹤0.01% 3009
2021
Q2
$30.8M Buy
159,544
+152,938
+2,315% +$30.3M 0.02% 883
2021
Q1
$1.37M Sell
6,606
-95,583
-94% -$20.3M ﹤0.01% 3884
2020
Q4
$19.2M Buy
102,189
+99,772
+4,128% +$16.3M 0.01% 1100
2020
Q3
$312 Buy
+2,417
New +$266K ﹤0.01% 3825
2020
Q2
Sell
-125,317
Closed -$7.55M 4368
2020
Q1
$7.55M Buy
+125,317
New +$9.27M 0.02% 1042
2019
Q3
Sell
-155,945
Closed -$9.46M 4356
2019
Q2
$9.46M Sell
155,945
-268,010
-63% -$14.4M 0.01% 1305
2019
Q1
$24.1M Buy
423,955
+150,876
+55% +$8.15M 0.04% 689
2018
Q4
$11.5M Buy
273,079
+209,048
+326% +$8.89M 0.02% 1038
2018
Q3
$2.69M Sell
64,031
-686,159
-91% -$32.2M ﹤0.01% 2219
2018
Q2
$26.8M Buy
+750,190
New +$24.2M 0.03% 700

Other funds holding INSP

Israel Englander's INSP Position: Q2 2026 in Review

Israel Englander reduced its Inspire Medical Systems (INSP) stake by 76% in Q2 2026, selling an estimated $13.8M and leaving 94,149 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3156.

Israel Englander first reported a position in INSP in Q2 2018 and has held it in 29 quarters since. The position peaked at $85.8M in Q2 2023. 274 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Israel Englander held 94,149 shares of Inspire Medical Systems worth $4.2M as of Q2 2026.
  • Israel Englander sold 291,997 Inspire Medical Systems shares in Q2 2026, an estimated $13.8M.
  • Inspire Medical Systems made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3156 holding.
  • Israel Englander first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 29 quarters since.
  • Israel Englander's Inspire Medical Systems position peaked at $85.8M in Q2 2023.
  • 274 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.